SCHEMBL483416

SCHEMBL483416

CCCc1nc2c(N)nc3ccccc3c2n1CCCCNC(=O)N1CCOCC1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 20/20 0.56
TLR8 Q9NR97 2/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30345388 1.00 TLR7 (0.56) TLR7TLR8
SCHEMBL4552763 0.93 TLR7 (0.61) TLR7TLR8
SCHEMBL4672516 0.91 TLR7 (0.63) TLR7
SCHEMBL5349922 0.89 TLR7 (0.52) TLR7TLR8
SCHEMBL5357638 0.88 TLR7 (0.63) TLR7
SCHEMBL5616978 0.88 TLR7 (0.58) TLR7TLR8
SCHEMBL13613797 0.87 TLR7 (0.57) TLR7TLR8
SCHEMBL29475743 0.87 TLR7 (0.57) TLR7TLR8
SCHEMBL5616945 0.87 TLR7 (0.57) TLR7TLR8
SCHEMBL5616997 0.87 TLR7 (0.56) TLR7TLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180155688-A1 METHOD FOR GENERATING HUMAN DENDRITIC CELLS FOR IMMUNOTHERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2018-06-07 US claimed
US-20250152703-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2025-05-15 US disclosed
US-12201684-B2 Compositions for stimulation of mammalian innate immune resistance to pathogens THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2025-01-21 US disclosed
US-20240417738-A1 IMMUNOTHERAPIES FOR THE TREATMENT OF CANCER OHIO STATE INNOVATION FOUNDATION 2024-12-19 US disclosed
CN-110234401-B Methods and compositions for adaptive immunomodulation 德克萨斯大学系统董事会 2024-03-01 CN disclosed
US-20240033348-A1 METHODS AND COMPOSITIONS FOR ADAPTIVE IMMUNE MODULATION Pulmotect, Inc. 2024-02-01 US disclosed
US-20240002799-A1 METHOD FOR GENERATING HUMAN DENDRITIC CELLS FOR IMMUNOTHERAPY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-01-04 US disclosed
US-11826422-B2 Methods and compositions for adaptive immune modulation BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-11-28 US disclosed
US-11680244-B2 Method for generating human dendritic cells for immunotherapy THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-20 US disclosed
EP-3298131-B1 METHOD FOR GENERATING HUMAN DENDRITIC CELLS FOR IMMUNOTHERAPY UNIV CALIFORNIA (US) 2023-04-26 EP disclosed
US-20150125492-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2015-05-07 US disclosed
WO-2015011254-A1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2015-01-29 WO disclosed
EP-2411521-B1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS UNIV TEXAS (US) 2015-01-14 EP disclosed
US-8883174-B2 Compositions for stimulation of mammalian innate immune resistance to pathogens THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2014-11-11 US disclosed
US-20120128715-A1 METHOD FOR STIMULATING THE IMMUNE RESPONSE OF NEWBORNS 3M INNOVATIVE PROPERTIES COMPANY (US) 2012-05-24 US disclosed
US-20120082700-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2012-04-05 US disclosed
EP-2411521-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS The Board of Regents of The University of Texas System (US) 2012-02-01 EP disclosed
WO-2010111485-A1 COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) 2010-09-30 WO disclosed
US-20080193468-A1 Method for Stimulating the Immune Response of Newborns CHILDREN'S MEDICAL CENTER CORPORATION (US) 2008-08-14 US disclosed
WO-2006029223-A2 METHOD FOR STIMULATING THE IMMUNE RESPONSE OF NEWBORNS CHILDREN'S MEDICAL CENTER CORPORATION (US) 2006-03-16 WO disclosed